HemaSphere (Jun 2022)

P364: DONOR-DERIVED CD19 CAR-T CELLS AND CHEMOTHERAPY PLUS DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF RECURRENT CD19+ B-ALL AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

  • X. Tan,
  • C. Zhang,
  • L. Gao,
  • L. Gao,
  • P. Kong,
  • Q. Wen,
  • S. Lou,
  • X. Zhang

DOI
https://doi.org/10.1097/01.HS9.0000844344.46206.8a
Journal volume & issue
Vol. 6
pp. 264 – 265

Abstract

Read online

No abstracts available.